Next Article in Journal
Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
Previous Article in Journal
Correction: McCart Reed et al. The Genomic Landscape of Lobular Breast Cancer. Cancers 2021, 13, 1950
 
 
Article

Article Versions Notes

Cancers 2021, 13(16), 4011; https://doi.org/10.3390/cancers13164011
Action Date Notes Link
article pdf uploaded. 9 August 2021 14:45 CEST Version of Record https://www.mdpi.com/2072-6694/13/16/4011/pdf-vor
article xml file uploaded 10 August 2021 09:23 CEST Original file -
article xml uploaded. 10 August 2021 09:23 CEST Update -
article pdf uploaded. 10 August 2021 09:23 CEST Updated version of record https://www.mdpi.com/2072-6694/13/16/4011/pdf-vor
article html file updated 10 August 2021 09:24 CEST Original file -
article supplementary file uploaded. 10 August 2021 09:26 CEST - https://www.mdpi.com/2072-6694/13/16/4011#supplementary
article html file updated 10 August 2021 09:27 CEST Update -
article xml file uploaded 10 August 2021 09:42 CEST Update -
article xml uploaded. 10 August 2021 09:42 CEST Update https://www.mdpi.com/2072-6694/13/16/4011/xml
article pdf uploaded. 10 August 2021 09:42 CEST Updated version of record https://www.mdpi.com/2072-6694/13/16/4011/pdf
article html file updated 10 August 2021 09:43 CEST Update -
article html file updated 10 August 2021 10:09 CEST Update -
article html file updated 28 July 2022 05:14 CEST Update https://www.mdpi.com/2072-6694/13/16/4011/html
Back to TopTop